Your weekly roundup of the latest news from Drug Topics®.
Artificial intelligence can be a key tool for streamlining pharmacy workflows.
Three new bills signed Monday will require PBMs to use prescription drug rebates to lower premiums and out-of-pocket costs for consumers and prevent the practice of spread pricing.
Researchers encourage physicians to personalize care plans to ensure that more patients adhere to their inhalers.
Underlying HIV infection was independently associated with neurocognitive long COVID symptoms.
A study examined STI rates following doxycycline post-exposure prophylaxis to see if it could reduce infection rates.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.